China's drug regulator granted Fuan Pharmaceutical (SHE:300194) subsidiary Fu'an Pharmaceutical Group Qingyutang Pharmaceutical approval for three injectables, according to a Friday disclosure to the Shenzhen bourse.
Mivacurium chloride injection is used together with anesthesia to help relax skeletal musicles, while polidocanol is used for varicose veins and cefoxitin sodium is indicated for severe lower respiratory tract infections, urinary tract infections, and intra-abdominal infections.
Haidilao International's (HKG:6862) Chair, CEO, and Controlling Shareholder Zhang Yong acquired nearly 11.4 million ordinary shares in the firm, according to a Friday filing with the Hong Kong bourse.The shares were purchased from the open market on Thursday and Friday for an average price of approximately HK$13.39 apiece.Zhang now, directly and indirectly, holds 2.09 billion shares in the hotpot operator, representing 37.56% of its total issued shares.
GuangDong Taili Technology (SHE:301595) will invest 30 million yuan to increase the capital of subsidiary Zhongshan Jianju, according to a Friday filing with the Shenzhen bourse.The amount comes from the proceeds of its initial public offering in 2025.The funds will help finance the construction of the Nano Valley Industrial Park research and development and production construction project.
Hangzhou Diagens Biotechnology's (HKG:2526) core product AI AutoVision obtained a Class III Medical Device Registration Certificate from China's National Medical Products Administration, according to a Friday filing with the Hong Kong bourse.The approved indications under the certificate cover chromosome karyotype analysis for the prenatal diagnosis for birth defects using amniotic fluid samples and assisted reproduction using peripheral blood samples.